Completed NA INTERVENTIONAL 2-arm NCT01186835

Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone

Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone: A Split-face, Rater-blinded Randomized Control Trial

Sponsor: Medicis Pharmaceutical Corporation

Conditions Forehead/Glabellar Rhytid Complexes

Interventions Botulinum Toxin A Combination Botulinum Toxin A and Hyaluronic Acid

Updated 6 times since 2017 Last updated: Dec 1, 2021 Started: Feb 28, 2011 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01186835, this NA trial focuses on Forehead/Glabellar Rhytid Complexes and remains completed. Sponsored by Medicis Pharmaceutical Corporation, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jan 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medicis Pharmaceutical Corporation
Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States